AAAAAA
Results:
1-8
|
Results: 8
Authors:
Comella, P
De Vita, F
Mancarella, S
De Lucia, L
Biglietto, M
Casaretti, R
Farris, A
Ianniello, GP
Lorusso, V
Avallone, A
Carteni, G
Leo, S
Catalano, G
De Lena, M
Comella, G
Citation: P. Comella et al., Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial, ANN ONCOL, 11(10), 2000, pp. 1323-1333
Authors:
Toma, S
Tucci, A
Villani, G
Carteni, G
Spadini, N
Palumbo, R
Citation: S. Toma et al., Liposomal Doxorubicin (Caelyx) in advanced pretreated Soft Tissue Sarcomas: A phase II study of the Italian Sarcoma Group (ISG), ANTICANC R, 20(1B), 2000, pp. 485-491
Authors:
Frasci, G
D'Aiuto, G
Comella, P
Thomas, R
Capasso, I
Di Bonito, M
Rivellini, F
Carteni, G
De Lucia, L
Maiorino, L
D'Aniello, R
Frezza, P
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97
Authors:
Caponigro, F
Avallone, A
McLeod, H
Carteni, G
De Vita, F
Casaretti, R
Morsman, J
Blackie, R
Budillon, A
De Lucia, L
Gravina, A
Catalano, G
Comella, P
Comella, G
Citation: F. Caponigro et al., Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer, CLIN CANC R, 5(12), 1999, pp. 3948-3955
Authors:
Frasci, G
Panza, N
Comella, P
Carteni, G
Guida, T
Nicolella, GP
Natale, M
Lombardi, R
Apicella, A
Pacilio, C
Gravina, A
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study, ANN ONCOL, 10(3), 1999, pp. 355-358
Authors:
Comella, P
Lorusso, V
Casaretti, R
De Lucia, L
Carteni, G
Manzione, L
Mancarella, S
De Lena, M
Comella, G
Citation: P. Comella et al., Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: An effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma - A multicenter phase II study of the Southern Italy Cooperative Oncology Group, TUMORI, 85(6), 1999, pp. 465-472
Authors:
Frasci, G
D'Aiuto, G
Comella, P
Apicella, A
Thomas, R
Capasso, I
Di Bonito, M
Carteni, G
Biglietto, M
Lucia, LD
Maiorino, L
Piccolo, S
Bianchi, U
D'Aniello, R
Lapenta, L
Comella, G
Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group, BREAST CANC, 56(3), 1999, pp. 239-252
Authors:
Caponigro, F
Comella, P
Marcolin, P
Spena, FR
Biglietto, M
Carteni, G
De Lucia, L
Avallone, A
Gravina, A
Comella, G
Citation: F. Caponigro et al., A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck, CANCER, 85(4), 1999, pp. 952-959
Risultati:
1-8
|